Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating Loss Carryforwards [Line Items]
Deferred tax assets valuation allowance	$ 37,237,362	$ 32,276,429
Deferred tax assets research and development	1,374,264	$ 1,374,264
Net Operating Loss Carryforwards Percentage		100.00%
Income tax penalties interest accrued	0	$ 0
CALIFORNIA
Operating Loss Carryforwards [Line Items]
Deferred tax assets research and development	730,000
NEW JERSEY
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	23,600,000
BioPharmX
Operating Loss Carryforwards [Line Items]
Deferred tax assets research and development	650,000
Operating loss carryforwards	80,400,000
BioPharmX | CALIFORNIA
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	71,300,000
Federal
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	$ 101,100,000
State
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards, expiration date	Dec. 31, 2040